2018-22101. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.Start Printed Page 51465

    Table 1—List of Information Collections Approved by OMB

    Title of collectionOMB control numberDate approval expires
    New Animal Drugs for Investigational Use0910-01178/31/2021
    Guidance for Industry and FDA Staff, Class II Special Controls: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle0910-05948/31/2021
    Petition to Request an Exemption from 100 Percent Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements0910-06088/31/2021
    Prescription Drug Advertisements0910-06868/31/2021
    Survey of the Occurrence of Foodborne Illness Risk Factors in Selected Retail and Foodservice Facility Types0910-07448/31/2021
    Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products0910-07598/31/2021
    Food and Cosmetic Export Certificate Applications Process0910-07938/31/2021
    Guidance for Industry: Medical Product Communications That are Consistent With the Food and Drug Administration Required Labeling—Questions and Answers0910-08568/31/2021
    Guidance for Industry: Drug and Device Manufacturer Communications with Payors, Formulary Committees, and Similar Entities Questions and Answers0910-08578/31/2021
    Guidance for Industry: Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies, Federal Facilities, and Certain Other Entities0910-08588/31/2021
    Drug Supply Chain Security Act Pilot Program0910-08598/31/2021
    Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Institutional and Retail Food Stores and Facility Types (2015-2025)0910-07999/30/2021
    Start Signature

    Dated: October 4, 2018.

    Leslie Kux,

    Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2018-22101 Filed 10-10-18; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
10/11/2018
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2018-22101
Pages:
51464-51465 (2 pages)
Docket Numbers:
Docket Nos. FDA-2018-N-0341, FDA-2012-N-0115, FDA-2018-N-1011, FDA-2010-N-0110, FDA-2012-N-0547, FDA-2014-N-2347, FDA-2016-D-2285, FDA-2016-D-1307, FDA-2016-D-4318, FDA-2016-N-0407, and FDA-2018-N-0270
PDF File:
2018-22101.pdf